Related references
Note: Only part of the references are listed.Excessive Neutrophils and Neutrophil Extracellular Traps Contribute to Acute Lung Injury of Influenza Pneumonitis
Teluguakula Narasaraju et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Effects of respiratory syncytial virus infection and major basic protein derived from eosinophils in pulmonary alveolar epithelial cells (A549)
Taisei Ishioka et al.
CELL BIOLOGY INTERNATIONAL (2011)
Successful Vaccination Strategies That Protect Aged Mice from Lethal Challenge from Influenza Virus and Heterologous Severe Acute Respiratory Syndrome Coronavirus
Timothy Sheahan et al.
JOURNAL OF VIROLOGY (2011)
Bacteria-Specific Neutrophil Dysfunction Associated with Interferon-Stimulated Gene Expression in the Acute Respiratory Distress Syndrome
Kenneth C. Malcolm et al.
PLOS ONE (2011)
How Innate Immune Mechanisms Contribute to Antibody-Enhanced Viral Infections
Sukathida Ubol et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Immunogenicity and Protective Efficacy in Mice and Hamsters of a β-Propiolactone Inactivated Whole Virus SARS-CoV Vaccine
Anjeanette Roberts et al.
VIRAL IMMUNOLOGY (2010)
Immunization with an attenuated severe acute respiratory syndrome coronavirus deleted in E protein protects against lethal respiratory disease
Jason Netland et al.
VIROLOGY (2010)
Immunogenicity of the spike glycoprotein of Bat SARS-like coronavirus
Yu-xuan Hou et al.
VIROLOGICA SINICA (2010)
Phylogenetic perspectives on the epidemiology and origins of SARS and SARS-like coronaviruses
Chi Wai Yip et al.
INFECTION GENETICS AND EVOLUTION (2009)
Differential characteristics of the early stage of lung inflammation induced by SARS-CoV Nucleocapsid protein related to age in the mouse
Y. G. Zhu et al.
INFLAMMATION RESEARCH (2009)
Alphavirus-Adjuvanted Norovirus-Like Particle Vaccines: Heterologous, Humoral, and Mucosal Immune Responses Protect against Murine Norovirus Challenge
Anna D. Lobue et al.
JOURNAL OF VIROLOGY (2009)
Early Upregulation of Acute Respiratory Distress Syndrome-Associated Cytokines Promotes Lethal Disease in an Aged-Mouse Model of Severe Acute Respiratory Syndrome Coronavirus Infection
Barry Rockx et al.
JOURNAL OF VIROLOGY (2009)
Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease
Maria Florencia Delgado et al.
NATURE MEDICINE (2009)
Comparison of Histochemical Methods for Murine Eosinophil Detection in an RSV Vaccine-enhanced Inflammation Model
David K. Meyerholz et al.
TOXICOLOGIC PATHOLOGY (2009)
A Neutralizing Human Monoclonal Antibody Protects against Lethal Disease in a New Ferret Model of Acute Nipah Virus Infection
Katharine N. Bossart et al.
PLOS PATHOGENS (2009)
Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines
Raymond H. See et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Cutting Edge: Eosinophils Do Not Contribute to Respiratory Syncytial Virus Vaccine-Enhanced Disease
Elaine M. Castilow et al.
JOURNAL OF IMMUNOLOGY (2008)
Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
Fumihiko Yasui et al.
JOURNAL OF IMMUNOLOGY (2008)
Structural basis for potent cross-neutralizing human monoclonal antibody protection against lethal human and zoonotic severe acute respiratory syndrome coronavirus challenge
Barry Rockx et al.
JOURNAL OF VIROLOGY (2008)
Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
Michelle M. Becker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The contribution of type I interferon signaling to immunity induced by alphavirus replicon vaccines
Joseph M. Thompson et al.
VACCINE (2008)
A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial
Julie E. Martin et al.
VACCINE (2008)
Alphavirus replicon particles acting as adjuvants promote CD8+ T cell responses to co-delivered antigen
Joseph M. Thompson et al.
VACCINE (2008)
Animal models and vaccines for SARS-CoV infection
Anjeanette Roberts et al.
VIRUS RESEARCH (2008)
Vaccines to prevent severe acute respiratory syndrome coronavirus-induced disease
Luis Enjuanes et al.
VIRUS RESEARCH (2008)
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome
Mark J. Cameron et al.
JOURNAL OF VIROLOGY (2007)
Potent cross-reactive neutralization of SARS coronavirus isolates by human monoclonal antibodies
Zhongyu Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Synthetic reconstruction of zoonotic and early human severe acute respiratory syndrome coronavirus isolates that produce fatal disease in aged mice
Barry Rockx et al.
JOURNAL OF VIROLOGY (2007)
Atypical measles and enhanced respiratory syncytial virus disease (ERD) made simple
Fernando P. Polack
PEDIATRIC RESEARCH (2007)
Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for Severe Acute Respiratory Syndrome coronavirus (SARS-CoV)
Leatrice N. Vogel et al.
VACCINE (2007)
Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists
Sarah A. Kopecky-Bromberg et al.
JOURNAL OF VIROLOGY (2007)
A mouse-adapted SARS-coronavirus causes disease and mortality in BALB/c mice
Anjeanette Roberts et al.
PLOS PATHOGENS (2007)
Vaccine efficacy in senescent mice challenged with recombinant SARS-CoV bearing epidemic and zoonotic spike variants
Damon Deming et al.
PLOS MEDICINE (2006)
Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
Hui Peng et al.
VIROLOGY (2006)
Supramolecular architecture of severe acute respiratory syndrome coronavirus revealed by electron ciyomicroscopy
Benjamin W. Neuman et al.
JOURNAL OF VIROLOGY (2006)
A potential molecular mechanism for hypersensitivity caused by formalin- inactivated vaccines
Amin Moghaddam et al.
NATURE MEDICINE (2006)
Specific epitopes of the structural and hypothetical proteins elicit variable humoral responses in SARS patients
SCS Chow et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
Mucosal and systemic adjuvant activity of alphavirus replicon particles
JM Thompson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Antibody response to influenza vaccination in the elderly: A quantitative review
K Goodwin et al.
VACCINE (2006)
A double-inactivated whole virus candidate SARS coronavirus vaccine
M Spruth et al.
VACCINE (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Bats are natural reservoirs of SARS-like coronaviruses
WD Li et al.
SCIENCE (2005)
A serological survey on neutralizing antibody titer of SARS convalescent sera
JS Zhang et al.
JOURNAL OF MEDICAL VIROLOGY (2005)
Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats
SKP Lau et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Comparison of single versus booster dose of influenza vaccination on humoral and cellular immune responses in older adults
JE McElhaney et al.
VACCINE (2005)
Aged BALB/c mice as a model for increased severity of severe acute respiratory syndrome in elderly humans
A Roberts et al.
JOURNAL OF VIROLOGY (2005)
B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein
XF Zhong et al.
JOURNAL OF VIROLOGY (2005)
Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human
HD Song et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice
TC Greenough et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice
H Bisht et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice
ZY Yang et al.
NATURE (2004)
Prior infection and passive transfer of neutralizing antibody prevent replication of severe acute respiratory syndrome coronavirus in the respiratory tract of mice
K Subbarao et al.
JOURNAL OF VIROLOGY (2004)
Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China
JF He et al.
SCIENCE (2004)
Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry
YX He et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Antigenicity analysis of different regions of the severe acute respiratory syndrome coronavirus nucleocapsid protein
ZL Chen et al.
CLINICAL CHEMISTRY (2004)
A subcutaneously injected UV-inactivated SARS coronavirus vaccine elicits systemic humoral immunity in mice
N Takasuka et al.
INTERNATIONAL IMMUNOLOGY (2004)
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
B Yount et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area
CM Booth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong
CA Donnelly et al.
LANCET (2003)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
Mechanisms of stimulation of the immune response by aluminum adjuvants
H HogenEsch
VACCINE (2002)
Share Paper
